Product: Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmaceuticals, Inc., Cincinnati, OH 43215, NDC 0591-0844-15
Reason for recall: Failed Moisture Limits: out of specification test results for water content obtained during stability testing.
Recall initiated: 20170802
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated